CO36 Network Meta-Analysis (NMA) to Assess Comparative Efficacy of Lenvatinib Plus Pembrolizumab Compared with Other First-Line Treatments for Management of Advanced Renal Cell Carcinoma (ARCC)
Abstract
Authors
A Kadambi A Pandey B Neupane K Fahrbach S Purushotham M Jones S Egodage A Kashyap J Pan